FMC Chehalis is a medicare approved dialysis facility center in Chehalis, Washington and it has 12 dialysis stations. It is located in Lewis county at 1684 Bishop Rd, Chehalis, WA, 98532. You can reach out to the office of FMC Chehalis at (360) 748-3964. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Chehalis has the following ownership type - Profit. It was first certified by medicare in August, 2002. The medicare id for this facility is 502539 and it accepts patients under medicare ESRD program.
| Name | FMC Chehalis |
|---|---|
| Location | 1684 Bishop Rd, Chehalis, Washington |
| No. of Dialysis Stations | 12 |
| Medicare ID | 502539 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 1684 Bishop Rd, Chehalis, Washington, 98532 | |
| (360) 748-3964 | |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
| NPI Number | 1043312218 |
| Doing Business As | Renal Care Group Northwest, Inc. |
| Address | 1684 Bishop Rd Chehalis, Washington, 98532 |
| Phone Number | (360) 748-3964 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 29 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 7 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 80 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 662 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
| Adult patients getting regular peritoneal dialysis at the center | 5 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 40 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Chehalis with elevated calcium levels.
| Patients with hypercalcemia | 90 |
| Hypercalcemia patient months | 773 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 91 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 23 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 22 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 28 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 64 |
| Patient months included in arterial venous fistula and catheter summaries | 510 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 75 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 11 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 68 |
| Hospitalization Rate in facility | 161.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 288.6 |
| Hospitalization Rate: Lower Confidence Limit | 93.6 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC Chehalis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 15.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 25.7 |
| Readmission Rate: Lower Confidence Limit | 8 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC Chehalis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.69 (As Expected) |
| SIR: Upper Confidence Limit | 3.22 |
| SIR: Lower Confidence Limit | .79 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC Chehalis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 63 |
| Transfusion Rate in facility | 14.2 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 59.9 |
| Transfusion Rate: Lower Confidence Limit | 4 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC Chehalis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 318 |
| Mortality Rate in facility | 13.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 18.8 |
| Mortality Rate: Lower Confidence Limit | 9.8 |
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago
News Archive
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.
Inhibitex, Inc. announced today that the Company was added to the broad-market Russell 3000® Index, as well as its Microcap and Global Indexes, when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on Friday June 25, 2010.
Yale scientists have systematically plotted the responses of the entire Drosophila (fruit fly) olfactory system, providing the first multi-dimensional map of the range of odorants sensed and the regions of the brain that are stimulated.
"Aid workers say malnutrition rates among children under five at the Dolo Ado camp [in Ethiopia] are alarming," with "[o]ver 50 percent of children in Dolo Ado's Hilaweyn camp and nearly half of all children in Kobe camp … suffering from malnutrition, according to a preliminary health survey from the United Nations refugee agency," Agence France-Presse reports.
› Verified 4 days ago